> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-8/
- Published: 2020-01-12T12:00:00.000Z
- Updated: 2026-09-14T15:58:21.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145831

[**Meeting on Asbestos in Talc and Cosmetic Products**](https://www.fdaweb.com/meeting-on-asbestos-in-talc-and-cosmetic-products/)  
*Federal Register* notice: FDA announces a 2/4 public meeting entitled “Testing Methods for Asbestos in Talc and Cosmetic Products Containing Talc.” 01/10/2020  

[**FDA Withdrawing 249 ANDAs Over Annual Reports**](https://www.fdaweb.com/fda-withdrawing-249-andas-over-annual-reports/)  
*Federal Register* notice: FDA proposes to withdraw approval of 249 ANDAs from multiple companies because they have repeatedly failed to file required annual reports. 01/09/2020  

[**Info Collection on Tissue Transplantation**](https://www.fdaweb.com/info-collection-on-tissue-transplantation/)  
*Federal Register* notice: FDA submits to OMB an information collection extension for “Human Tissue Intended for Transplantation — 21 CFR Part 1270.” 01/09/2020  

[**Info Collection on Administrative Practice/Procedures**](https://www.fdaweb.com/info-collection-on-administrative-practice-procedures/)  
*Federal Reg*ister notice: FDA seeks comments on an information collection revision for “General Administrative Practice and Procedures.” 01/09/2020  

[**Public Meeting on Modernizing FDA Data Strategy**](https://www.fdaweb.com/public-meeting-on-modernizing-fda-data-strategy/)  
*Federal Register* notice: FDA announces a 3/27 public meeting entitled “Modernizing FDA’s Data Strategy.” 01/08/2020  

[**Comments Extended on Certificates of Confidentiality Guide**](https://www.fdaweb.com/comments-extended-on-certificates-of-confidentiality-guide/)  
*Federal Register* notice: FDA extends until 1/24 the comment period for a draft guidance entitled “Certificates of Confidentiality; Guidance for Sponsors, Sponsor-Investigators, Researchers, Industry, and Food and Drug Administration Staff.” 01/08/2020  

[**FDA Focus Group Info Collection Extension**](https://www.fdaweb.com/fda-focus-group-info-collection-extension/)  
*Federal Register* notice: FDA seeks comments on an information collection extension on “Focus Groups as Used by the Food and Drug Administration (All FDA-Regulated Products).” 01/08/2020  

[**Comments Extended on Homeopathic Drug Guide**](https://www.fdaweb.com/comments-extended-on-homeopathic-drug-guide/)  
*Federal Register* notice: FDA extends until 3/23 the comment period on a revised draft guidance entitled “Drug Products Labeled as Homeopathic.” 01/08/2020